Corient Private Wealth’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Buy |
+101,206
| New | +$425K | ﹤0.01% | 1879 |
|
|
2025
Q1 | – | Sell |
-20,203
| Closed | -$77 | – | 2322 |
|
|
2024
Q4 | $77 | Buy |
20,203
+6,431
| +47% | +$25 | ﹤0.01% | 2348 |
|
|
2024
Q3 | $123K | Hold |
13,772
| – | – | ﹤0.01% | 2270 |
|
|
2024
Q2 | $134K | Buy |
13,772
+1,891
| +16% | +$18.4K | ﹤0.01% | 2172 |
|
|
2024
Q1 | $161K | Buy |
11,881
+4,297
| +57% | +$58.3K | ﹤0.01% | 2125 |
|
|
2023
Q4 | $83K | Buy |
7,584
+5,279
| +229% | +$57.8K | ﹤0.01% | 2168 |
|
|
2023
Q3 | $23.6K | Buy |
2,305
+14
| +0.6% | +$143 | ﹤0.01% | 2102 |
|
|
2023
Q2 | $36.2K | Sell |
2,291
-14
| -0.6% | -$221 | ﹤0.01% | 2019 |
|
|
2023
Q1 | $52.1K | Buy |
2,305
+1,851
| +408% | +$41.9K | ﹤0.01% | 1921 |
|
|
2022
Q4 | $16.2K | Buy |
+454
| New | +$16.2K | ﹤0.01% | 1665 |
|